David O Clarke - Lilly Corp Ctr | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 10 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Exploring Greater Flexibility for Chronic Toxicity Study Designs to Support Human Safety Assessment While Balancing 3rs Considerations

Helen Prior,Paul Baldrick,David O Clarke, Elisa Passini,Fiona Sewell,Peter van Meer

International journal of toxicologyno. 5 (2024): 456-463

Cited0Views0WOSBibtex

Opportunities and Challenges for Use of Minipigs in Nonclinical Pharmaceutical Development: Results of a Follow-Up IQ DruSafe Survey

David O. Clarke,Kaushik Datta, Kevin French,Michael W. Leach, Drew Olaharski, Susanne Mohr, Devon Strein,Jeanine Bussiere, Bianca Feyen,Beatrice E. Gauthier, Michael Graziano,Joanna Harding, Kenneth Hershman, Binod Jacob, Shaofei Ji, Robert Lange,Smita Salian-Mehta, Brian Sayers, Nicole Thomas, Thierry Flandre

REGULATORY TOXICOLOGY AND PHARMACOLOGY (2024)

Cited0Views0WOSBibtex

Exploring the Definition of “similar Toxicities”: Case Studies Illustrating Industry and Regulatory Interpretation of ICH S6(R1) for Long-Term Toxicity Studies in One or Two Species

Helen Prior,David O. Clarke,David Jones, Eleni Salicru,Melissa M. Schutten,Fiona Sewell

INTERNATIONAL JOURNAL OF TOXICOLOGY（2022）

Cited3Views0WOSBibtex

Opportunities for Use of One Species for Longer-Term Toxicology Testing During Drug Development: A Cross-Industry Evaluation

Helen Prior,Paul Baldrick,Sonja Beken,Helen Booler,Nancy Bower, Paul Brooker,Paul Brown,Brian Burlinson,Leigh Ann Burns-Naas,Warren Casey,Melissa Chapman,David Clarke,Lolke de Haan, Olaf Doehr,Noel Downes, Meghan Flaherty,Nichola Gellatly,Sophia Gry Moesgaard, Jennifer Harris,Mark Holbrook, Julia Hui,David Jones,Keith Jones, Hilla Kedar, Andreas Mahl, Alli Manninen, Aidan McGuire,Elisabeth Mortimer-Cassen,Marjorie Peraza,Michael K. Pugsley, Jacques Richard,Ruth Roberts,Wendy Roosen,Andreas Rothfuss, Ankie Schoenmakers,Fiona Sewell,Richard Weaver,Lucinda Weir,Alison Wolfreys,Ian Kimber

Regulatory toxicology and pharmacology（2020）

Cited29Views0WOSBibtex

Strategies and Recommendations for Using a Data‐Driven and Risk‐Based Approach in the Selection of First‐in‐Human Starting Dose: an International Consortium for Innovation and Quality in Pharmaceutical Development (IQ) Assessment

Michael W. Leach,David O. Clarke,Sherri Dudal,Chao Han,Chunze Li,Zheng Yang,Frank R. Brennan,Wendy J. Bailey,Yingxue Chen,Antoine Deslandes,Lise I. Loberg,Kapil Mayawala,Mark C. Rogge,Marque Todd, Nagendra V. Chemuturi

Clinical Pharmacology & Therapeutics（2020）

Cited19Views0WOSBibtex

An Assessment of the Central Disposition of Intranasally Administered Insulin Lispro in the Cerebrospinal Fluid of Healthy Volunteers and Beagle Dogs

Stephen Lowe,Emanuele Sher,Graham Wishart,Kimberley Jackson,Eunice Yuen,Claire Brittain,Siew Chinn Fong,David O. Clarke,William H. Landschulz

Drug Delivery and Translational Research（2016）

Cited8Views0WOSBibtex

The Use of Minipigs for Preclinical Safety Assessment by the Pharmaceutical Industry

Curtis Colleton,David Brewster,Anne Chester,David O. Clarke,Peter Heining,Andrew Olaharski,Michael Graziano

Toxicologic Pathology（2016）

Cited36Views0WOSBibtex

A Review of the Abuse Potential Assessment of Atomoxetine: a Nonstimulant Medication for Attention-Deficit/hyperactivity Disorder

Himanshu P. Upadhyaya,Durisala Desaiah,Kory J. Schuh,Frank P. Bymaster,Mary J. Kallman,David O. Clarke,Todd M. Durell,Paula T. Trzepacz,David O. Calligaro,Eric S. Nisenbaum,Paul J. Emmerson,Leslie M. Schuh,Warren K. Bickel,Albert J. Allen

Psychopharmacology（2013）

Cited54Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn